This company is no longer active
The company may no longer be operating, as it may be out of business. Find out why through their latest events.
Tricida Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Tricida.
Key information
57.3%
Earnings growth rate
58.1%
EPS growth rate
| Pharmaceuticals earnings growth | 22.8% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 29 Mar 2023 |
Recent future growth updates
Recent updates
Tricida enters $125M debt facility
Oct 19Tricida: Important Binary Event Coming Up
Sep 21Calculating The Intrinsic Value Of Tricida, Inc. (NASDAQ:TCDA)
Sep 14
Insider Buying: The Tricida, Inc. (NASDAQ:TCDA) CFO & Executive VP Just Bought 6.5% More Shares
Dec 14Tricida revises VALOR-CKD trial protocol, updates patent protection, shares down 14%
Dec 09Tricida's Veverimer CRL And Regulatory Updates: An Analysis
Nov 17Tricida slumps 46% on FDA feedback on veverimer proposal; launches cost-cutting initiatives
Oct 29Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2023 | N/A | -58 | -29 | -29 | 1 |
| 12/31/2022 | N/A | -109 | -89 | -89 | 1 |
| 9/30/2022 | N/A | -134 | -109 | -109 | N/A |
| 6/30/2022 | N/A | -148 | -119 | -119 | N/A |
| 3/31/2022 | N/A | -153 | -136 | -135 | N/A |
| 12/31/2021 | N/A | -177 | -140 | -140 | N/A |
| 9/30/2021 | N/A | -181 | -145 | -144 | N/A |
| 6/30/2021 | N/A | -219 | -177 | -176 | N/A |
| 3/31/2021 | N/A | -244 | -212 | -211 | N/A |
| 12/31/2020 | N/A | -265 | -233 | -231 | N/A |
| 9/30/2020 | N/A | -268 | -220 | -219 | N/A |
| 6/30/2020 | N/A | -235 | -202 | -201 | N/A |
| 3/31/2020 | N/A | -213 | -158 | -157 | N/A |
| 12/31/2019 | N/A | -177 | -131 | -130 | N/A |
| 9/30/2019 | N/A | -146 | -134 | -133 | N/A |
| 6/30/2019 | N/A | -131 | -119 | -118 | N/A |
| 3/31/2019 | N/A | -120 | -104 | -104 | N/A |
| 12/31/2018 | N/A | -103 | -96 | -95 | N/A |
| 9/30/2018 | N/A | -96 | -79 | -78 | N/A |
| 6/30/2018 | N/A | -77 | -60 | -58 | N/A |
| 3/31/2018 | N/A | -60 | -49 | -47 | N/A |
| 12/31/2017 | N/A | -41 | -41 | -40 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: TCDA.Q is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: TCDA.Q is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: TCDA.Q is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: Insufficient data to determine if TCDA.Q's revenue is forecast to grow faster than the US market.
High Growth Revenue: TCDA.Q is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if TCDA.Q's Return on Equity is forecast to be high in 3 years time